Literature DB >> 2478685

New monoclonal antibodies recognizing epidermal differentiation-associated keratins in formalin-fixed, paraffin-embedded tissue. Keratin 10 expression in carcinoma of the vulva.

D Ivanyi1, A Ansink, E Groeneveld, P C Hageman, W J Mooi, A P Heintz.   

Abstract

Two monoclonal antibodies (MAb) specific for differentiation-related epidermal keratins have been developed. They represent specific molecular probes for different stages of epidermal differentiation. Antibody DE-K10 is chain-specific for cytokeratin polypeptide no. 10 (56.5 kD) expressed in all suprabasal layers of the epidermis. Antibody DE-SCK is specific for modified stratum corneum keratins and thus represents a marker for the terminal step of epidermal differentiation. Since the epitopes identified by both antibodies are preserved in formalin-fixed, paraffin-embedded tissue sections, these antibodies can be used for retrospective studies of differentiation in various pathological processes. We have used antibody DE-K10 to study the cytokeratin 10 expression in 26 stage II or III vulvar squamous cell carcinomas. Preliminary data suggest an increased risk of recurrence in cytokeratin 10 negative tumours.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478685     DOI: 10.1002/path.1711590105

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  12 in total

1.  Detection of keratin subtypes in routinely processed cervical tissue: implications for tumour classification and the study of cervix cancer aetiology.

Authors:  F Smedts; F Ramaekers; M Link; L Lauerova; S Troyanovsky; C Schijf; G P Vooijs
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

2.  The Expression Pattern of Epidermal Differentiation Marker Keratin 10 in the Normal Human Breast and Breast Cancer Cells.

Authors:  Jiyoung Kim; René Villadsen
Journal:  J Histochem Cytochem       Date:  2020-07-03       Impact factor: 2.479

3.  The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells.

Authors:  Daisuke Suzuki; Raju Sahu; N Adrian Leu; Makoto Senoo
Journal:  Development       Date:  2014-12-11       Impact factor: 6.868

4.  p107 is a suppressor of retinoblastoma development in pRb-deficient mice.

Authors:  E Robanus-Maandag; M Dekker; M van der Valk; M L Carrozza; J C Jeanny; J H Dannenberg; A Berns; H te Riele
Journal:  Genes Dev       Date:  1998-06-01       Impact factor: 11.361

5.  Bone marrow stromal cells, preadipocytes, and dermal fibroblasts promote epidermal regeneration in their distinctive fashions.

Authors:  Shigehisa Aoki; Shuji Toda; Takashi Ando; Hajime Sugihara
Journal:  Mol Biol Cell       Date:  2004-08-03       Impact factor: 4.138

6.  Changes in expression of differentiation markers between normal ovarian cells and derived tumors.

Authors:  C C Van Niekerk; F C Ramaekers; A G Hanselaar; J Aldeweireldt; L G Poels
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

7.  Cytokeratin 18 expression in squamous cell carcinoma of the head and neck.

Authors:  A J Balm; P C Hageman; M H van Doornewaard; E M Groeneveld; D Ivanyi
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

8.  Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice.

Authors:  E C Maandag; M van der Valk; M Vlaar; C Feltkamp; J O'Brien; M van Roon; N van der Lugt; A Berns; H te Riele
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

Review 9.  The human keratins: biology and pathology.

Authors:  Roland Moll; Markus Divo; Lutz Langbein
Journal:  Histochem Cell Biol       Date:  2008-05-07       Impact factor: 4.304

10.  The δ-opioid receptor affects epidermal homeostasis via ERK-dependent inhibition of transcription factor POU2F3.

Authors:  Christine Neumann; Mei Bigliardi-Qi; Christian Widmann; Paul L Bigliardi
Journal:  J Invest Dermatol       Date:  2014-09-01       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.